Earnings Labs
Forte Biosciences, Inc. logo

Forte Biosciences, Inc. (FBRX) Earnings Dates & History

NASDAQ·Healthcare·Biotechnology

$26.49

-1.16%

Mkt Cap $381.16M

EPS — Estimate vs Actual

Revenue — Estimate vs Actual

Quarterly History

Q1 2026

Mar 31, 2026

-$1.42-$1.45-2.11%
Q4 2025

Nov 14, 2025

-$1.04-$0.99+4.81%
Q3 2025

Aug 14, 2025

-$1.21-$0.96+20.66%
Q2 2025

May 15, 2025

-$0.89-$1.37-53.93%
Q1 2025

Mar 24, 2025

-$4.55-$2.45+46.15%
Q4 2024

Nov 14, 2024

-$6.75-$4.54+32.74%
Q3 2024

Aug 14, 2024

-$4.00-$6.75-68.75%
Q2 2024

May 13, 2024

-$0.16-$4.00-2400.00%
Q1 2024

Mar 18, 2024

$6.00K-$0.28-$1.00-257.14%
Q4 2023

Nov 13, 2023

-$14.25-$6.50+54.39%
Q3 2023

Aug 14, 2023

-$10.50
Q2 2023

May 15, 2023

-$8.00
Q1 2023

Mar 31, 2023

-$0.16-$6.00-3650.00%
Q4 2022

Nov 14, 2022

-$0.15-$4.50-2900.00%
Q3 2022

Aug 15, 2022

-$0.17-$5.25-2988.24%
Q2 2022

May 16, 2022

-$0.17-$4.25-2400.00%
Q1 2022

Mar 31, 2022

-$0.07-$5.25-7400.00%
Q4 2021

Nov 8, 2021

-$7.25-$13.50-86.21%
Q3 2021

Aug 16, 2021

-$10.00-$10.75-7.50%
Q2 2021

May 10, 2021

-$9.75-$9.00+7.69%
Q1 2021

Mar 16, 2021

-$0.57-$0.37+35.09%
Q4 2020

Nov 9, 2020

-$8.00-$11.50-43.75%
Q3 2020

Aug 10, 2020

-$0.19-$238.00-125163.16%
Q2 2020

Apr 23, 2020

-$6.60-$6.45+2.27%
Q1 2020

Feb 27, 2020

$10.26K$9.00K-12.28%-$8.55-$7.50+12.28%
Q4 2019

Nov 12, 2019

-$10.49-$11.70-11.53%
Q3 2019

Aug 8, 2019

-$11.34-$10.80+4.76%
Q2 2019

May 7, 2019

$11.40K$9.00K-21.09%-$15.15-$11.10+26.73%
Q1 2019

Feb 27, 2019

-$10.26-$14.40-40.35%
Q4 2018

Nov 8, 2018

-$6.75-$0.30+95.56%
Q3 2018

Aug 7, 2018

-$8.90-$12.15-36.52%
Q2 2018

May 10, 2018

-$242.64
Q1 2018

Mar 8, 2018

-$9.37-$8.25+11.95%
Q4 2017

Nov 8, 2017

-$8.62-$7.50+12.99%
Q3 2017

Aug 9, 2017

-$7.80-$8.40-7.69%
Q2 2017

May 23, 2017

-$40.42-$61.65-52.52%